CALL TO ACTION: dear readers, please do yourself and everyone else a favour and write the European 'public health bodies' an email (addresses and template included)

Here's my plan: use their own words (from the EMA) against national authorities thart defer to the EMA

Yesterday, I shared written proof that the European Medicines Agency (EMA) cannot answer questions about the safety of a 4th injection all the while European countries rely on the EMA to ‘justify’ offering yet another booster jab.

It’s a shitshow, start to finish, and it’s very much indicative of the wayward thinking and, yes, relates to issues of criminal justice: the notion of ‘I just obeyed orders’ was the line the Nazi bigwigs used in the dock in Nuremberg to defend themselves as they tried to shift the blame—and their responsibility—on the dead Führer they followed so blindly for so many years (the ‘argument’ was thrown out).

Since I’ve obtained that written message from the EMA as part of my journalistic moonlighting efforts, I’ve been trying to reach out to more people about this, hence today’s repeated call.

So, if you haven’t done so and have a few minutes to spare, please take a look at the below listing of ‘public health’ bodies across Europe (the continent), for they all collaborate with the EMA:

Austria: pharm-vigilanz@ages.at

Belgium: vig@fagg.be

Bulgaria: pharmacovig@bda.bg

Croatia: pripravnost@halmed.hr

Cyprus: phv@phs.moh.gov.cy

Czech Republic: farmakovigilance@sukl.cz

Denmark: LMU@dkma.dk

Estonia: pharmacovig@ravimiamet.ee

Finland: TURVA@fimea.fi

France: pharmacovigilance@ansm.sante.fr

Germany / BfArM: esi@bfarm.de

Germany / PEI: pharmakovigilanz1@pei.de

Greece: pv-esi@eof.gr

Hungary: adr.box@ogyei.gov.hu

Ireland: medvigilance@hpra.ie

Italy: esi@aifa.gov.it

Latvia: info@zva.gov.lv

Lithuania: NepageidaujamaR@vvkt.lt; GintareGilaite@vvkt.lt

Malta: postlicensing.medicinesauthority@gov.mt

Netherlands: nlhphar@cbg-meb.nl

Norway: adr@noma.no

Poland: signals-esi@urpl.gov.pl

Portugal: info.seguranca@infarmed.pt

Romania: farmacovigilenta@anm.ro

Slovakia: pharmacovigilance@sukl.sk

Slovenia: h-farmakovigilanca@jazmp.si

Spain: fvigilancia@aemps.es

Sweden: RIC@mpa.se

United Kingdom (Northernd Ireland): signalmanagement@mhra.gsi.gov.uk

SOURCE: https://www.ema.europa.eu/documents/other/emerging-safety-issues-esi-contact-points-national-competent-authority-nca-level_en.xlsx

If you’re out of words or don’t have much time right now, please feel free to peruse the below template:

---

Dear madams and sirs,

As the 4th vaccination (2nd booster) of the current Covid-19 products is rolled out, I’m writing you to enquire about the safety and efficacy data.

It has come to my attention that the European Medicines Agency (EMA) deems any questions pertaining to repeat dose toxicity, vaccine efficacy, or the stopping conditions are ‘complex’ and seemingly cannot be answered right away. In an email, the EMA acknowledged that it would take up to two months before any such answers or data would be forthcoming.

Given that these injectable products have caused harm (see the EUDRA Vigilance database, but note that, e.g., in Norway there are already 260 dead and close to 60,000 adverse reactions logged as of mid-June, on which see https://legemiddelverket.no/Documents/Bivirkninger%20og%20sikkerhet/Rapporter%20og%20oversikter/Koronavaksiner/20220616%20Rapport%20over%20meldte%20bivirkninger%20av%20koronavaksine.pdf), I would like to obtain answers from you to the following questions:

Is there any stopping condition that would cause the public health authorities to recommend pausing the mass vaccination campaign with these injectable products?

The original conditional marketing authorisation by the European Medicines Agency was given for a two-dose protocol. As the fourth dose is being rolled out, are there any further studies that address toxicology, specifically repeated administration of these products? If so, please share the data with me.

Given that these deaths are mainly (suspectedly) associated with the mRNA products by BioNTech/Pfizer and Moderna, did the public health authorities receive any funding whatsoever for education, training, or promotional materials from any of these companies?

Thank you for a timely response.

Yours, sincerely: [sign your name]

---

For those readers in Germany and Austria, here’s a German-language version (which I sent to both the Austrian pharmacovigilance institution and the Ministry of Health yesterday):

---

Sehr geehrte Damen und Herren,

diesr Tage wird die 4. Dosis der Korona-Impfungen angeboten bzw. breit diskutiert, weswegen ich mich an Sie betreffend die Sicherheit dieser 2. Auffrischungsimpfung wende.

Seitens der Europäischen Arzneimittelbehörde sind Fragen zu der wiederholten Verabreichung der verfügbaren Wirkstoffe sowie nach den Bedingungen, die einen Stopp der Impfkampagne nach sich ziehen würden (etwa Anzahl Impfreaktionen, inkl. Todesfälle), mit dem Verweis, dass dies "komplexe" Fragen seien und es "rund zwei Monate" dauern würde, bis eine Antwort vorliegt, beantwortet worden (s. die beigeschlossene Email).

In Norwegen alleine sind mit 14. Juni 2022 bereits 260 Todesfälle und knapp 60.000 Impfreaktionen registriert wurden, wie die offiziellen Angaben ausweisen (siehe https://legemiddelverket.no/Documents/Bivirkninger%20og%20sikkerhet/Rapporter%20og%20oversikter/Koronavaksiner/20220616%20Rapport%20over%20meldte%20bivirkninger%20av%20koronavaksine.pdf).

Angesichts dieser Sachlage wünsche ich von Seiten der AGES Antworten auf die folgenden Fragen zu erlangen:

1. Welche Konditionen (z.B. Impfreaktionen und Sicherheitsbedenken, niedrige Effektivität) müssen seitens der AGES erreicht werden, um eine Unterbrechung oder Einstellung der Impfkampagne zu rechtfertigen?

2. Die bedingte Marktzulassen seitens der Europäischen Arzneimittelbehörde wurde bekanntlich für eine aus zwei Impfdosen bestehende Serie gegeben. Nun wird die 4. Dosis angeboten, weswegen ich von der AGES gerne erfahren möchte, auf welcher Datenbasis dies geschieht, insbesondere die Sicherheit der wiederholten Verabreichung dieser Produkte betreffend.

3. Da die Mehrheit der (vermuteten) Impfreaktionen auf die Verabreichung der mRNA-Wirkstoffe von BioNTech/Pfizer bzw. Moderna erfolgten, möchte ich zudem erfahren ob--und wenn ja, wieviel und an wen--Geld- bzw. Sachmittel oder dergleichen von diesen Unternehmen an die Gesundheitsbehörden geflossen sind.

Vielen Dank für Ihre zeitnahe Antwort.

Mit besten Grüßen, [your name]

---

Please take a few minutes and send as many such emails as possible. Invite your friends to do so, too, and let’s swamp their inboxes.

Remember: there were approx. 35,000 public comments on the WHO website concerning the very problematic amendments of the International Health Regulations earlier this year.

There were approx. 200,000 comments lodged by Austrian citizens who expressed their concerns about the (ultimately revoked) injection mandate (to make this as plain as I can: Austria has some 9m inhabitants, the US approx. 325m: hence, these 200,000 comments are the equivalent of 7.1m comments in the US context, or a huge number in comparison).

These things ‘work’ (to a certain extent), but I wish to conclude today’s call to action with the following two reasons why you should follow through with this:

1. We need but one country becoming wobbly in their commitment to this shitshow to signal to other almost-as-wobbly countries that they can come out of their hiding places. I am convinced that we’re getting very close to this particular breaking point.

2. Also, since I know that rational arguments won’t do it, the one thing that might affect any change in these regards would be, in my experience and estimation, to use their own ‘arguments’ and hold them up publicly. In other words: shaming them into either admitting that they screwed up and lose their faces (and incomes) OR making them come up with any ‘reason’ to shift topic and quietly phase out a problematic program. You know, such as the mass vaccination campaign with these injectable products.

So, please take a few moments and send these emails.

Thank you, sincerely.